Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/15 → 2/27/19 |
Funding
- Children’s Hospital of Philadelphia
- Novartis Pharmaceuticals Corporation
ADVL1322: A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory SolidTumors.
- Walterhouse, David O (PD/PI)
Project: Research project